Replies to post #170239 on Biotech Values

[mcbio]

As investors, we can get caught up in the business side of the biotech industry to such an extent that one can lose sight of the astonishing scientific progress in some areas. Incivek was the greatest advance in the history of HCV treatment, but in only 2.5 years on the market it’s become irrelevant.

Yep, agree completely. Any chance JNJ ends up losing on this transaction? Just can't see much life left in Incivek.